ReoPro abciximab: Marketed

By WIR Staff | Mar 15, 1999 | 8:00 AM GMT

CNTO and partner Eli Lilly and Co. announced preliminary 30-day data from the Phase II ADMIRAL (abciximab before direct angioplasty and stenting in myocardial infarction regarding acute and long-term